Tinavi Medical Technologies Co Ltd Cash Flow Conversion Efficiency
Tinavi Medical Technologies Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥24.50 Million ≈ $3.59 Million USD) by net assets (CN¥1.29 Billion ≈ $189.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Tinavi Medical Technologies Co Ltd (2013–2025)
Cash flow conversion efficiency of Tinavi Medical Technologies Co Ltd from 2013 to 2025. This chart illustrates how Tinavi Medical Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688277 share price today for real-time trading data and today's change.
Tinavi Medical Technologies Co Ltd Cash Flow Conversion Ratio Explained
Tinavi Medical Technologies Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Tinavi Medical Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their cash flow conversion efficiency. Also see Tinavi Medical Technologies Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zoomlion Heavy Industry Science and Technology Co. Ltd
F:8CZ
|
0.019x |
|
Under Armour Inc A
NYSE:UAA
|
0.194x |
|
STEVANATO GROUP SPA O.N.
F:87N
|
0.021x |
|
Weibo Corporation
F:2WBA
|
0.062x |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
0.123x |
|
Neuberger Berman Next Generation Connectivity Fund Inc
NYSE:NBXG
|
N/A |
|
Allied Machinery Co. Ltd.
SHG:605060
|
N/A |
|
Harbin Electric
F:HP6H
|
0.036x |
Annual Cash Flow Conversion Efficiency for Tinavi Medical Technologies Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Tinavi Medical Technologies Co Ltd from 2013 to 2025. Review 688277 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.01 Billion ≈ $439.93 Million |
CN¥-51.17 Million ≈ $-7.49 Million |
-0.017x | +77.92% |
| 2024-12-31 | CN¥1.28 Billion ≈ $187.32 Million |
CN¥-98.65 Million ≈ $-14.44 Million |
-0.077x | +44.06% |
| 2023-12-31 | CN¥1.24 Billion ≈ $181.09 Million |
CN¥-170.50 Million ≈ $-24.95 Million |
-0.138x | -75.95% |
| 2022-12-31 | CN¥1.12 Billion ≈ $163.54 Million |
CN¥-87.51 Million ≈ $-12.80 Million |
-0.078x | -7.51% |
| 2021-12-31 | CN¥1.07 Billion ≈ $156.22 Million |
CN¥-77.76 Million ≈ $-11.38 Million |
-0.073x | -29.85% |
| 2020-12-31 | CN¥1.03 Billion ≈ $150.22 Million |
CN¥-57.58 Million ≈ $-8.43 Million |
-0.056x | -262.91% |
| 2019-12-31 | CN¥596.34 Million ≈ $87.26 Million |
CN¥20.53 Million ≈ $3.00 Million |
0.034x | +46.76% |
| 2018-12-31 | CN¥560.61 Million ≈ $82.04 Million |
CN¥13.15 Million ≈ $1.92 Million |
0.023x | -30.62% |
| 2017-12-31 | CN¥169.41 Million ≈ $24.79 Million |
CN¥5.73 Million ≈ $838.18K |
0.034x | +114.13% |
| 2016-12-31 | CN¥136.62 Million ≈ $19.99 Million |
CN¥-32.70 Million ≈ $-4.78 Million |
-0.239x | -216.74% |
| 2015-12-31 | CN¥203.98 Million ≈ $29.85 Million |
CN¥41.82 Million ≈ $6.12 Million |
0.205x | +132.02% |
| 2014-12-31 | CN¥52.84 Million ≈ $7.73 Million |
CN¥-33.84 Million ≈ $-4.95 Million |
-0.640x | -460.95% |
| 2013-12-31 | CN¥29.60 Million ≈ $4.33 Million |
CN¥-3.38 Million ≈ $-494.53K |
-0.114x | -- |
About Tinavi Medical Technologies Co Ltd
Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more